Vertex Pharmaceuticals
VRTX
#185
Rank
NZ$191.76 B
Marketcap
NZ$754.88
Share price
-4.56%
Change (1 day)
-11.14%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2025 (TTM): NZ$7.95 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are NZ$12.00 Billion. , an increase over its 2024 earnings that were of NZ$0.48 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2025

Annual earnings

Year Earnings Change
2025 NZ$8.11 B1568.4%
2024 NZ$0.48 B-93.69%
2023 NZ$7.71 B3.19%
2022 NZ$7.47 B53.56%
2021 NZ$4.86 B-12.06%
2020 NZ$5.53 B118.45%
2019 NZ$2.53 B120.64%
2018 NZ$1.14 B1473.64%
2017 NZ$72.96 M197.6%
2016 NZ$24.51 M-102.97%
2015 -NZ$0.83 Billion-28.46%
2014 -NZ$1.16 Billion-51.5%
2013 -NZ$2.38 Billion-30584.68%
2012 NZ$7.8 M-95.47%
2011 NZ$0.17 B
2009 -NZ$1.04 Billion
2007 -NZ$0.72 Billion83.1%
2006 -NZ$0.4 Billion59.02%
2005 -NZ$0.25 Billion3.28%
2004 -NZ$0.24 Billion-38.16%
2003 -NZ$0.39 Billion
2000 -NZ$66.32 Million-20.38%
1999 -NZ$83.29 Million31.62%
1998 -NZ$63.28 Million91.05%
1997 -NZ$33.12 Million-36.24%
1996 -NZ$51.95 Million12.45%
1995 -NZ$46.2 Million27.4%
1994 -NZ$36.26 Million-1833.33%
1993 NZ$2.09 M-112.12%
1992 -NZ$17.26 Million175%
1991 -NZ$6.28 Million-12.2%
1990 -NZ$7.15 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$58.48 B 620.54%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$11.49 B 41.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$17.07 B 110.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$39.08 B 381.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$16.25 B 100.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
-NZ$0.14 Billion-101.63%๐Ÿ‡บ๐Ÿ‡ธ USA